ATE332371T1 - Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese - Google Patents

Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese

Info

Publication number
ATE332371T1
ATE332371T1 AT00943373T AT00943373T ATE332371T1 AT E332371 T1 ATE332371 T1 AT E332371T1 AT 00943373 T AT00943373 T AT 00943373T AT 00943373 T AT00943373 T AT 00943373T AT E332371 T1 ATE332371 T1 AT E332371T1
Authority
AT
Austria
Prior art keywords
nucleic acid
synthesis
relates
inhibitors
compositions
Prior art date
Application number
AT00943373T
Other languages
English (en)
Inventor
Mekbib Astatke
Deb Chatterjee
Gary Gerard
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Application granted granted Critical
Publication of ATE332371T1 publication Critical patent/ATE332371T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00943373T 1999-07-02 2000-06-30 Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese ATE332371T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14207299P 1999-07-02 1999-07-02

Publications (1)

Publication Number Publication Date
ATE332371T1 true ATE332371T1 (de) 2006-07-15

Family

ID=22498453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00943373T ATE332371T1 (de) 1999-07-02 2000-06-30 Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese

Country Status (8)

Country Link
EP (1) EP1196559B1 (de)
JP (2) JP2003504018A (de)
AT (1) ATE332371T1 (de)
AU (1) AU782555B2 (de)
CA (1) CA2377780A1 (de)
DE (1) DE60029225T2 (de)
NZ (1) NZ516894A (de)
WO (1) WO2001002559A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1367136A4 (de) 2001-02-15 2005-01-12 Takara Bio Inc Verfahren zum nachweis von nukleotidpolymorphismus
BR0314236A (pt) * 2002-09-13 2005-08-09 Replicor Inc Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos
ATE541055T1 (de) * 2004-10-18 2012-01-15 Univ Brandeis Reagenzien und verfahren zur verbesserung der reproduzierbarkeit und zur reduzierung des mispriming bei der pcr-amplifikation
US8530194B2 (en) 2005-09-26 2013-09-10 Allelogic Biosciences Corporation Oligonucleotides as temperature-sensitive inhibitors for DNA polymerases
US20070212704A1 (en) 2005-10-03 2007-09-13 Applera Corporation Compositions, methods, and kits for amplifying nucleic acids
US7781165B2 (en) 2005-10-19 2010-08-24 Roche Diagnostics Operations, Inc. Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification
SG190377A1 (en) 2010-11-24 2013-06-28 Kaneka Corp Amplified nucleic acid detection method and detection device
WO2013154898A1 (en) * 2012-04-12 2013-10-17 Ong, Jennifer Synthetic nucleic acids for polymerization reactions
JP6219816B2 (ja) * 2012-04-27 2017-10-25 株式会社カネカ 核酸の増幅方法、および、増幅核酸の検出方法
WO2015076356A1 (ja) * 2013-11-22 2015-05-28 株式会社カネカ 短鎖ｒｎａの検出方法
WO2019135975A1 (en) * 2018-01-05 2019-07-11 Stratos Genomics Inc. Enhancement of nucleic acid polymerization by aromatic compounds
KR102275038B1 (ko) 2019-12-11 2021-07-08 (주) 제노텍 대립 유전자의 구분성을 높이는 pcr 방법 및 pcr 킷트
JP2023531027A (ja) * 2020-06-22 2023-07-20 ▲蘇▼州新海生物科技股▲ふん▼有限公司 核酸リガンド、およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763173A (en) * 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
US6020130A (en) * 1995-06-07 2000-02-01 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands that bind to and inhibit DNA polymerases
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations

Also Published As

Publication number Publication date
DE60029225T2 (de) 2007-07-05
CA2377780A1 (en) 2001-01-11
WO2001002559A9 (en) 2002-07-25
EP1196559A1 (de) 2002-04-17
AU5785000A (en) 2001-01-22
DE60029225D1 (de) 2006-08-17
JP2011041572A (ja) 2011-03-03
AU782555B2 (en) 2005-08-11
WO2001002559A1 (en) 2001-01-11
EP1196559B1 (de) 2006-07-05
JP2003504018A (ja) 2003-02-04
NZ516894A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
Martin et al. Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: footprinting and enzyme inhibition studies
ATE332371T1 (de) Zusammensetzungen und verfahren zu höhere empfindlichkeit und spezifität von nukleinsäuresynthese
DE69503129D1 (de) Pteridin-nukleotidderivate als fluoreszierende sonden
Wang et al. RNA Conformation in the Tat− TAR Complex Determined by Site-Specific Photo-Cross-Linking
Ohtsuki et al. The minimal tRNA: unique structure of Ascaris suum mitochondrial tRNASerUCU having a short T arm and lacking the entire D arm
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
ATE380883T1 (de) Direkte multiplex charakterisierung von genomischer dna
NO973685L (no) Multi-tumor avvikende vekstgener
DK0587266T3 (da) Fremgangsmåde, sammensætning og kit til nukleinsyreamplifikation
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
TR199802385T2 (xx) TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler.
DK0519053T3 (da) Nucleinsyreamplifikation med DNA-afhængig RNA-polymeraseaktivitet hos RNA-replicaser
Ramon et al. Effects of 8-oxo-7, 8-dihydro-2′-deoxyguanosine on the binding of the transcription factor Sp1 to its cognate target DNA sequence (GC box)
AU4345401A (en) Nucleic acid sensor molecules
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
ATE255595T1 (de) Nephrin gen und protein
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
Kolpashchikov et al. Synthesis of base-substituted dUTP analogues carrying a photoreactive group and their application to study human replication protein A
ATE174634T1 (de) Verfahren und proben zum nachweis von mit dem locus der infantilen spinalamyotrophien verbundenen markern
DE60025011D1 (de) Dna polymerase lambda und ihre verwendungen
BR0001906A (pt) Processo para a preparação fermentativa de l-aminoácidos usando bactérias corineformes
BRPI0407292A (pt) Uso de um ácido nucleico, da correlação direta entre a super-expressão ou a modificação molecular funcional de homólogos humanos da famìlia sgk e a extensão do intervalo q/t, de um anticorpo dirigido contra um substrato de um homólogo humano da famìlia sgk, de um ativador funcional, ou de um regulador de transcrição positivo, de um homólogo humano da famìlia sgk e uso de substâncias selecionadas dentre o grupo consistindo de glucocorticóides, mineralocorticóides, aldosterona, gonadotropinas e citocinas, kit e método para diagnosticar hipertensão, kit para diagnosticar a sìndrome de qt longo e fármaco
Inga et al. N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic
DE60040874D1 (de) Amplifizierung von hiv-1 sequenzen zur detektion ven einhergehen
WO2002017947A3 (de) Verwendung von t-proteinen zur differentiellen charakterisierung und therapie von verletzungen und tumoren des nervensystems

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties